NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M
The Fly

NeuroPace raises FY24 revenue view to $78M-$80M from $76M-$78M

Consensus $77.1M. Sees FY24 gross margin 72%-74%. The company said, “NeuroPace (NPCE) continues to expect revenue growth to be primarily driven by increasing sales of its RNS System, supported by higher sales of DIXI Medical stereo EEG products.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App